PMID- 28605406 OWN - NLM STAT- MEDLINE DCOM- 20180720 LR - 20220316 IS - 1367-4811 (Electronic) IS - 1367-4803 (Print) IS - 1367-4803 (Linking) VI - 33 IP - 19 DP - 2017 Oct 1 TI - CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens. PG - 3110-3112 LID - 10.1093/bioinformatics/btx375 [doi] AB - SUMMARY: We present CloudNeo, a cloud-based computational workflow for identifying patient-specific tumor neoantigens from next generation sequencing data. Tumor-specific mutant peptides can be detected by the immune system through their interactions with the human leukocyte antigen complex, and neoantigen presence has recently been shown to correlate with anti T-cell immunity and efficacy of checkpoint inhibitor therapy. However computing capabilities to identify neoantigens from genomic sequencing data are a limiting factor for understanding their role. This challenge has grown as cancer datasets become increasingly abundant, making them cumbersome to store and analyze on local servers. Our cloud-based pipeline provides scalable computation capabilities for neoantigen identification while eliminating the need to invest in local infrastructure for data transfer, storage or compute. The pipeline is a Common Workflow Language (CWL) implementation of human leukocyte antigen (HLA) typing using Polysolver or HLAminer combined with custom scripts for mutant peptide identification and NetMHCpan for neoantigen prediction. We have demonstrated the efficacy of these pipelines on Amazon cloud instances through the Seven Bridges Genomics implementation of the NCI Cancer Genomics Cloud, which provides graphical interfaces for running and editing, infrastructure for workflow sharing and version tracking, and access to TCGA data. AVAILABILITY AND IMPLEMENTATION: The CWL implementation is at: https://github.com/TheJacksonLaboratory/CloudNeo. For users who have obtained licenses for all internal software, integrated versions in CWL and on the Seven Bridges Cancer Genomics Cloud platform (https://cgc.sbgenomics.com/, recommended version) can be obtained by contacting the authors. CONTACT: jeff.chuang@jax.org. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. CI - (c) The Author(s) 2017. Published by Oxford University Press. FAU - Bais, Preeti AU - Bais P AD - The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. FAU - Namburi, Sandeep AU - Namburi S AD - The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. FAU - Gatti, Daniel M AU - Gatti DM AD - The Jackson Laboratory, Bar Harbor, ME 04609, USA. FAU - Zhang, Xinyu AU - Zhang X AD - The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. FAU - Chuang, Jeffrey H AU - Chuang JH AD - The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030, USA. AD - Department of Genetics and Genome Sciences, University of Connecticut Health, Farmington, CT 06032, USA. LA - eng GR - P30 CA034196/CA/NCI NIH HHS/United States GR - R21 CA191848/CA/NCI NIH HHS/United States PT - Journal Article PL - England TA - Bioinformatics JT - Bioinformatics (Oxford, England) JID - 9808944 RN - 0 (Antigens, Neoplasm) RN - 0 (Peptides) SB - IM MH - Antigens, Neoplasm/chemistry/*genetics MH - Genomics MH - *High-Throughput Nucleotide Sequencing MH - Histocompatibility Testing MH - Humans MH - Mutation MH - Peptides/chemistry/genetics MH - *Software MH - Workflow PMC - PMC5870764 EDAT- 2017/06/13 06:00 MHDA- 2018/07/22 06:00 PMCR- 2017/06/12 CRDT- 2017/06/13 06:00 PHST- 2016/11/14 00:00 [received] PHST- 2017/06/07 00:00 [accepted] PHST- 2017/06/13 06:00 [pubmed] PHST- 2018/07/22 06:00 [medline] PHST- 2017/06/13 06:00 [entrez] PHST- 2017/06/12 00:00 [pmc-release] AID - 3866879 [pii] AID - btx375 [pii] AID - 10.1093/bioinformatics/btx375 [doi] PST - ppublish SO - Bioinformatics. 2017 Oct 1;33(19):3110-3112. doi: 10.1093/bioinformatics/btx375.